Advertisement

How the Pulmonary Function Laboratory Contributes to the Management of the Patient With Asthma

  • Richard E. Kanner
  • Theodore G. Liou
Chapter
Part of the Current Clinical Practice book series (CCP)

Abstract

  • Spirometry is a dynamic test that provides the best assessment of obstructive airway disease.

  • The most useful value that the spirogram provides is the maximum volume of air that can be expelled with a forced expiration after a maximal inspiratory effort, the forced expiratory volume in 1 s (FEV1).

  • Lung volume measurements are static studies and are less useful in assessing airway obstruction but can demonstrate the presence of pulmonary overinflation.

  • The carbon monoxide-diffusing capacity can help distinguish between asthma and emphysema in patients who smoke.

  • Arterial blood gas studies can assess the consequences of bronchospasm and provide a guide for hospitalizing patients with asthma exacerbation.

  • Nonspecific bronchoprovocation challenge testing with methacholine or other agents may help diagnose asthma when the clinical picture is unclear.

  • Bronchoprovocation challenge testing using specific agents can help diagnose asthma caused by workplace substances.

  • Standardization of technique and rigid quality control are an absolute necessity in any pulmonary laboratory.

Keywords

Lung Volume Forced Vital Capacity Functional Residual Capacity Forced Expiratory Volume Total Lung Capacity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Harris TR, Pratt PC, Kilburn KH. Total lung capacity measured by roentgenograms. Am J Med 1971;50:756–763.PubMedCrossRefGoogle Scholar
  2. 2.
    Gardner RM, Baker CD, Broennle AM, et al. ATS statement—snowbird workshop on standardization of spirometry. Am Rev Respir Dis 1979;119: 831–838.Google Scholar
  3. 3.
    Crapo RO, Hankinson JL, Irvin C, et al. Standardization of spirometry. Am J Respir Crit Care Med 1995;152: 1107–1136.Google Scholar
  4. 4.
    Crapo RO, Hankinson JL, Irvin C, et al. Single-breath carbon monoxide diffusing capacity (transfer factor), recommendations for a standard technique—1995 update. Am J Respir Crit Care Med 1995;152: 2185–2198.Google Scholar
  5. 5.
    Miller MR, Crapo R, Hankinson J, et al. General Considerations for Lung Function Testing. Eur Respir J 2005;26: 153–161.PubMedCrossRefGoogle Scholar
  6. 6.
    Morris AH, Kanner RE, Crapo RO, et al. (eds.) Clinical Pulmonary Function Testing: A Manual of Uniform Laboratory Procedures. 2nd ed. Salt Lake City, UT, Intermountain Thoracic Society, 1984.Google Scholar
  7. 7.
    Conrad SA, Kinasewitz GT, George RB (eds). Pulmonary Function Testing. Principles and Practice. New York, Churchill Livingstone, 1984.Google Scholar
  8. 8.
    Enright PL, Johnson LJ, Connett JE, et al. Spirometry in the lung health study: 1. Methods and quality control. Am Rev Respir Dis 1991;143: 1215–1223.PubMedGoogle Scholar
  9. 9.
    Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123: 659–664.PubMedGoogle Scholar
  10. 10.
    Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159: 179–187.PubMedGoogle Scholar
  11. 11.
    Becklake M, Crapo RO, Buist S, et al. Lung function testing: Selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144: 1202–1218.Google Scholar
  12. 12.
    Watanabe S, Renzetti AD Jr, Begin R, et al. Airway responsiveness to a bronchodilator aerosol. Am Rev Respir Dis 1974;109: 530–537.PubMedGoogle Scholar
  13. 13.
    Light RW, Conrad SA, George RB. The one best test for evaluating the effects of bronchodilator therapy. Chest 1977;72: 512–516.PubMedCrossRefGoogle Scholar
  14. 14.
    Woolcock AJ, Read J. Lung volumes in exacerbations of asthma. Am J Med 1966;41: 259–273.PubMedCrossRefGoogle Scholar
  15. 15.
    Juniper EF, Frith PA, Dunnett C, et al. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978;33: 705–710.PubMedCrossRefGoogle Scholar
  16. 16.
    Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challengetesting—1999. Am J Respir Crit Care Med 2000;161: 309–329.PubMedGoogle Scholar
  17. 17.
    Chan-Yeung M. Occupational asthma. Chest 1990;98(Supplement): 148S–161S.CrossRefGoogle Scholar
  18. 18.
    Chan-Yeung M, Harber P, Bailey W, et al. Guidelines for the evaluation of impairment/disability in patients with asthma. A statement of the American Thoracic Society. Am Rev Respir Dis 1993;147: 1056–1061.Google Scholar

Copyright information

© Humana Press Inc. 2006

Authors and Affiliations

  • Richard E. Kanner
    • 1
  • Theodore G. Liou
    • 1
  1. 1.Division of Respiratory, Critical Care and Occupational Medicine, Department of MedicineUniversity of Utah School of MedicineSalt Lake City

Personalised recommendations